Study finds new possible risk factor of heart disease

02/15/11 Abnormal heart rate turbulence is associated with an increased risk of heart disease death in otherwise low-risk older individuals, according to a study funded by the National Heart, Lung, and Blood Institute (NHLBI), part of the National Institutes of Health.

+

-

 

NIH stops clinical trial on combination cholesterol treatment

05/26/11 The National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health has stopped a clinical trial studying a blood lipid treatment 18 months earlier than planned. The trial found that adding high dose, extended-release niacin to statin treatment in people with heart and vascular disease, did not reduce the risk of cardiovascular events, including heart attacks and stroke.

+

-

 

Cholesterol Drug Combination Shows No Added Heart Benefits

05/29/11   Cholesterol drugs in combination with each other have been found not to provide extra heart benefits, according to a new study. ABC News reports that researchers at the National Heart Lung and Blood Institute have concluded their trial involving the two drugs a year and a half ahead of time due to the discouraging findings....

+

-